NCT07068958View on ClinicalTrials.gov

A Study Evaluating the Efficacy and Safety of RCI001 Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

August 1, 2025

Primary Completion Date

November 1, 2025

Study Completion Date

November 1, 2025

Conditions

Dry Eye Disease (DED)

Interventions

DRUG

0.25% RCI001 Ophthalmic Solution

0.25% RCI001 Ophthalmic Solution

DRUG

Placebo Ophthalmic Solution (vehicle)

Placebo Ophthalmic Solution (vehicle)

All Listed Sponsors

lead

ORA, Inc.

INDUSTRY